Document Detail


The Absorption Profile of Pregabalin in Chronic Pancreatitis.
MedLine Citation:
PMID:  22716224     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
It was recently shown that pregabalin decreased pain associated with chronic pancreatitis. It is well known that pancreatitis patients suffer from fat malabsorption with accompanying diarrhoea due to loss of exocrine pancreatic enzyme production. This may lead to changes in the mucosal surface in the small intestine and possibly affect the absorption of pregabalin. The pharmacokinetics of pregabalin has never been investigated in patients suffering from chronic pancreatitis. The aim of this study was to develop a population pharmacokinetic model of pregabalin administered to patients with chronic pancreatitis. The pregabalin population pharmacokinetic analysis was conducted on data from fifteen patients with chronic pancreatitis. Each patient received 75 mg of pregabalin (oral capsule). Pregabalin concentrations were measured using a validated liquid chromatographic method. Data analysis was performed using non-linear mixed effects modeling methodology as implemented by NONMEM. A one compartment model with first-order absorption and elimination adequately described pregabalin pharmacokinetics. Time to maximum observed plasma concentration (T(max) ) was 1.53 (95%CI 1.09-2.05). The maximum plasma concentration (C(max) ) was 1.98 μg/ml (95%CI 1.69-2.34) and area under the plasma concentration-time profile (AUC) was 18.2 μg*h/ml (95%CI 14.7-26.3). Pregabalin is well absorbed in patients with chronic pancreatitis and the pharmacokinetic profile of pregabalin is not extensively affected by chronic pancreatitis.
Authors:
Anne Estrup Olesen; Erik Olofsen; Søren Schou Olesen; Camilla Staahl; Trine Andresen; Albert Dahan; Asbjørn Mohr Drewes
Related Documents :
6662754 - The syed-neblett interstitial template in locally advanced gynecological malignancies.
21944474 - Gait pattern classification in children with charcot-marie-tooth disease type 1a.
21988704 - The added value of quantitative analysis of on-therapy impedance-ph parameters in disti...
902244 - Transthoracic needle biopsy of mediastinal and hilar lesions.
1985354 - Coronary angioplasty of diffuse coronary artery disease.
696714 - Clinical value of liver scans.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-6-21
Journal Detail:
Title:  Basic & clinical pharmacology & toxicology     Volume:  -     ISSN:  1742-7843     ISO Abbreviation:  -     Publication Date:  2012 Jun 
Date Detail:
Created Date:  2012-6-21     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101208422     Medline TA:  Basic Clin Pharmacol Toxicol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 The Authors Basic & Clinical Pharmacology & Toxicology © 2012 Nordic Pharmacological Society.
Affiliation:
Mech-Sense, Department of Gastroenterology, Aalborg Hospital, Aarhus University Hospital, Denmark.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Viral protease inhibitors affect the production of virulence factors in Cryptococcus neoformans.
Next Document:  Puberty as a life history transition.